肺动脉瓣置换术中内生隔绝技术对右心室重构的影响:心脏磁共振评估
本研究对比法洛四联症修复术后肺动脉瓣置换术中使用与不使用内生隔绝技术的安全性和有效性。纳入86例患者(46例使用内生隔绝,40例不使用),中位随访4.45年。结果显示两组生存率、再干预率、结构性瓣膜 deterioration 及右心室功能均无显著差异。
要点
- 内生隔绝技术不增加再干预或结构性瓣膜 deterioration 风险
- 两组右心室舒张末期容积指数和射血分数无显著差异
- 内生隔绝允许瓣膜植入无结构变形,短中期结果良好
核心结论
- 肺动脉瓣置换术中使用或不使用内生隔绝技术均安全有效。
- 使用内生隔绝技术允许瓣膜植入无结构变形,短中期结果良好。
研究设计与样本
- 46例使用内生隔绝技术,40例不使用,中位随访4.45年(范围1.9个月至9.87年)。
主要发现
- 无30天死亡。
- 7年免于再干预率:不使用内生隔绝组97%,使用组94%(log-rank P=0.68)。
- 7年免于结构性肺动脉瓣 deterioration 率:不使用组94%,使用组89%(log-rank P=0.94)。
- 右心室舒张末期容积指数:不使用组102.2±34 ml/m2,使用组93.3±22 ml/m2(P=0.61)。
- 右心室射血分数:不使用组46±11%,使用组46±9%(P=0.88)。
关键数值与推荐
- 7年免于再干预率不使用内生隔绝组97% vs 使用组94%(log-rank P=0.68)。
- 7年免于结构性肺动脉瓣 deterioration 率不使用组94% vs 使用组89%(log-rank P=0.94)。
- 右心室舒张末期容积指数不使用组102.2±34 ml/m2 vs 使用组93.3±22 ml/m2(P=0.61)。
- 右心室射血分数不使用组46±11% vs 使用组46±9%(P=0.88)。
临床怎么用
- 在肺动脉瓣置换术中可考虑使用内生隔绝技术以避免瓣膜结构变形。
- 内生隔绝技术未增加再干预或瓣膜 deterioration 风险,短中期安全有效。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Pulmonary valve replacement (PVR) performed for pulmonary valve regurgitation is the most common indication for reoperation during mid-to-long-term follow-up after tetralogy of Fallot repair. An aneurysmal dilation of the infundibulum is often associated secondary to the infundibulotomy performed in the first operation. The right ventricular outflow tract reconstruction with endo-exclusion aims to exclude the non-contractile segments of the dilated right ventricular. This study intends to assess the safety and efficiency of the endo-exclusion technique. METHODS: Between January 2010 and December 2018, 86 patients underwent a PVR with (n = 46) or without (n = 40) endo-exclusion. The current study compares the outcomes in terms of survival, reintervention, structural valve deterioration, right ventricular function (volume and right ventricular ejection fraction) and pulmonary valve gradient. The median follow-up time was 4.45 years (1.9 months to 9.87 years). RESULTS: There was no 30-day mortality. There was no difference in the freedom from reintervention at 7 years (without endo-exclusion, 97%, versus with endo-exclusion, 94%, log-rank = 0.68) or in the freedom from structural pulmonary valve deterioration at 7 years (without endo-exclusion, 94%, versus with endo-exclusion, 89%, log-rank = 0.94). No significant difference was observed in the indexed right ventricular end-diastolic volume (102.2 ± 34 ml/m2 in the PVR without endo-exclusion group and 93.3 ± 22 ml/m2 in the PVR with endo-exclusion group, P = 0.61). No significant difference was observed in the right ventricular function (right ventricular ejection fraction: 46 ± 11% in the PVR without endo-exclusion group and 46 ± 9% in the PVR with endo-exclusion group, P = 0.88). CONCLUSIONS: PVR with or without endo-exclusion is a safe and effective procedure. PVR with endo-exclusion allows implantation without structural deformation of the valve and therefore excellent short- and medium-term results.
引用
- Lenoir M, Chenu C, Amrous A, et al. Right ventricular remodelling after endo-exclusion during pulmonary valve replacement: evaluation by cardiac magnetic resonance. Eur J Cardiothorac Surg. 2021. PMID: 33880522. doi:10.1093/ejcts/ezab185
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。